Crinetics stock nearly doubled Tuesday after Vertex Pharmaceuticals pledged $10 billion to buy the e...
Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles
Crinetics stock nearly doubled Tuesday after Vertex Pharmaceuticals pledged $10 billion to buy the endocrinology-focused biotech company.
Author: Investor's Business Daily
Read Original Article